Profil
Dan Touitou is the founder of Novel Therapeutic Technologies, Inc. Prior to that, he served as the Chief Executive Officer of Juvenis Ltd. and NeuroQuest Ltd. He also worked as a Principal at OTC Markets Group, Inc. Mr. Touitou holds a Master's in Business Administration from the University of Derby and an undergraduate degree from The Hebrew University of Jerusalem.
Anciens postes connus de Dan Touitou
| Sociétés | Poste | Fin |
|---|---|---|
NeuroQuest Ltd.
NeuroQuest Ltd. Medical SpecialtiesHealth Technology Develops blood-based diagnostic test for Alzheimer's disease | Directeur Général | - |
Novel Therapeutic Technologies, Inc. | Fondateur | - |
| OTC MARKETS GROUP INC. | Corporate Officer/Principal | - |
Juvenis Ltd.
Juvenis Ltd. BiotechnologyHealth Technology Develops biosynthetic biomaterials | Directeur Général | - |
Formation de Dan Touitou
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
OTC Markets Group, Inc.
OTC Markets Group, Inc. Investment Banks/BrokersFinance Operates open, transparent and connected financial marketplaces | Finance |
University of Derby
University of Derby Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novel Therapeutic Technologies, Inc. | |
Juvenis Ltd.
Juvenis Ltd. BiotechnologyHealth Technology Develops biosynthetic biomaterials | Health Technology |
NeuroQuest Ltd.
NeuroQuest Ltd. Medical SpecialtiesHealth Technology Develops blood-based diagnostic test for Alzheimer's disease | Health Technology |
















